Health & Fitness
Wed, November 27, 2024Tue, November 26, 2024Mon, November 25, 2024Thu, November 14, 2024Tue, November 12, 2024Sat, June 10, 2017Sat, June 3, 2017Wed, May 31, 2017Wed, May 17, 2017Fri, May 12, 2017Thu, May 11, 2017Tue, May 9, 2017Thu, May 4, 2017Thu, April 20, 2017Fri, April 14, 2017Thu, March 23, 2017Fri, March 17, 2017Thu, March 9, 2017Sat, March 4, 2017Fri, March 3, 2017Thu, March 2, 2017Wed, February 15, 2017Mon, February 13, 2017Wed, February 8, 2017Thu, February 2, 2017Fri, January 13, 2017Wed, January 11, 2017Wed, January 4, 2017Fri, December 16, 2016Thu, December 15, 2016Mon, December 12, 2016Thu, December 8, 2016Wed, November 23, 2016Mon, November 14, 2016Sun, November 13, 2016Wed, November 9, 2016Thu, November 3, 2016Wed, November 2, 2016Mon, October 17, 2016Sat, October 8, 2016Thu, October 6, 2016Wed, October 5, 2016Mon, October 3, 2016Fri, September 30, 2016Thu, September 29, 2016Tue, September 27, 2016Mon, September 26, 2016Fri, September 23, 2016Thu, September 22, 2016Wed, September 21, 2016Tue, September 20, 2016Mon, September 19, 2016Sun, September 18, 2016Fri, September 16, 2016Thu, September 15, 2016Wed, September 14, 2016Mon, September 12, 2016Fri, September 9, 2016Thu, May 9, 2013Wed, May 8, 2013Tue, May 7, 2013Mon, May 6, 2013Sun, May 5, 2013Fri, May 3, 2013Thu, May 2, 2013Wed, May 1, 2013Tue, April 30, 2013Quidel to Present at Bank of America Merrill Lynch 2013 Health Care Conference
Published in Health and Fitness on Wednesday, May 8th 2013 at 16:15 GMT by Market Wire
May 08, 2013 19:00 ET
Quidel to Present at Bank of America Merrill Lynch 2013 Health Care Conference
SAN DIEGO, CA--(Marketwired - May 8, 2013) - Quidel Corporation (
Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present that day at 12:20 p.m. Eastern time (9:20 a.m. Pacific time) with a question and answer session scheduled immediately following the presentation. During the presentation, the company will discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.
A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company's Web site at [ www.quidel.com ]. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company's Web site for 14 days.
About Quidel Corporation
Quidel Corporation serves to enhance the health and well being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the QuickVue®, D3® Direct Detection and Thyretain® leading brand names, as well as under the new Sofia® and AmpliVue® brands, Quidel's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, [ influenza ], [ respiratory syncytial virus ], Strep A, herpes, pregnancy, [ thyroid disease ] and [ fecal occult blood ]. Quidel's research and development engine is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians' offices and hospital and reference laboratories. For more information about Quidel's comprehensive product portfolio, visit [ www.quidel.com ] and Diagnostic Hybrids at [ www.dhiusa.com ].
